Education
About Us
Working with TipRanks
Follow Us
QuiaPEG Pharmaceuticals Holding AB (DE:99B0)
:99B0
99B0 Stock Chart & Stats
$0.01
>-$0.01(-9.09%)
At close: 4:00 PM EST
$0.01
>-$0.01(-9.09%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume0.00
Average Volume (3M)N/A
Market Cap
€97.85K
Enterprise ValueN/A
Total Cash (Recent Filing)€4.00K
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta16.24
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,124,285,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.23
Price to Sales (P/S)8.19
P/FCF Ratio-0.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
99B0 FAQ
What was QuiaPEG Pharmaceuticals Holding AB’s price range in the past 12 months?
Currently, no data Available
What is QuiaPEG Pharmaceuticals Holding AB’s market cap?
QuiaPEG Pharmaceuticals Holding AB’s market cap is €97.85K.
When is QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date?
QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date is Aug 27, 2026 which is in 249 days.
How were QuiaPEG Pharmaceuticals Holding AB’s earnings last quarter?
QuiaPEG Pharmaceuticals Holding AB released its earnings results on Aug 28, 2025. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
Is QuiaPEG Pharmaceuticals Holding AB overvalued?
According to Wall Street analysts QuiaPEG Pharmaceuticals Holding AB’s price is currently Overvalued.
Does QuiaPEG Pharmaceuticals Holding AB pay dividends?
QuiaPEG Pharmaceuticals Holding AB does not currently pay dividends.
What is QuiaPEG Pharmaceuticals Holding AB’s EPS estimate?
QuiaPEG Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does QuiaPEG Pharmaceuticals Holding AB have?
QuiaPEG Pharmaceuticals Holding AB has 2,124,285,000 shares outstanding.
What happened to QuiaPEG Pharmaceuticals Holding AB’s price movement after its last earnings report?
QuiaPEG Pharmaceuticals Holding AB reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of QuiaPEG Pharmaceuticals Holding AB?
Currently, no hedge funds are holding shares in DE:99B0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
QuiaPEG Pharmaceuticals Holding AB
QUIA PHARMA AB engages in the research, development, and commercialization of drug delivery system. Its product, Uni-Qleaver®, uses releasable pegylation technology that eliminates potential drawbacks and adjusts the drug's half-life. The company was founded by Marek Kwiatkowski and is headquartered in Uppsala, Sweden.
Stayble Therapeutics AB
―
LIDDS AB
―
Lipigon Pharmaceuticals AB
―
Modus Therapeutics Holding AB
―
CombiGene AB
―